Long gamma nail versus sliding hip screw for the treatment of unstable pertrochanteric hip fractures

ISRCTN ISRCTN79362886
DOI https://doi.org/10.1186/ISRCTN79362886
Protocol serial number N/A
Sponsor North Bristol NHS Trust (UK)
Funder North Bristol NHS Trust (UK)
Submission date
26/03/2009
Registration date
07/04/2009
Last edited
07/04/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Timothy Chesser
Scientific

Department of Trauma and Orthopaedics
Frenchay Hospital
Frenchay Park Road
Frenchay
Bristol
BS16 1JE
United Kingdom

Study information

Primary study designInterventional
Study designSingle centre randomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA prospective randomised controlled trial comparing the long gamma nail with the sliding hip screw for the treatment of unstable pertrochanteric hip fractures
Study objectivesThere is no difference in outcome between the sliding hip screw and the long gamma nail in the treatment of unstable pertrochanteric hip fractures.
Ethics approval(s)South West Local Research Ethics Committee approved on the 12th May 2003 (ref: Frenchay LREC/2003/20)
Health condition(s) or problem(s) studiedUnstable pertrochanteric fractures of the proximal femur
InterventionPatients entered into the trial were randomised to fixation of their proximal femoral fracture by either a sliding hip screw (Omega® II, Stryker, UK) or a long gamma nail (Dyax®, Stryker, UK).

Randomisation was via sealed envelopes. Neither participants nor physicians were blinded to treatment.
Intervention typeOther
Primary outcome measure(s)

Re-operation within the first post-operative year.

Key secondary outcome measure(s)

1. Mortality in the first post-operative year
2. Requirement for a blood transfusion within one week of surgery
3. Length of hospital stay
4. Mobility and residency at one year
5. Euroqol EQ-5D at 3, 6 and 12 months post-operation

Completion date01/04/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration320
Key inclusion criteriaAll patients (both males and females) over the age of 18 years admitted to the treating hospital with an unstable pertrochanteric hip fracture.
Key exclusion criteria1. Pathological fractures
2. Previous proximal femoral fractures
3. Decision of the admitting physician
Date of first enrolment01/04/2003
Date of final enrolment01/04/2006

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Department of Trauma and Orthopaedics
Bristol
BS16 1JE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2010 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes